» Articles » PMID: 23648337

AXL and MET Crosstalk to Promote Gonadotropin Releasing Hormone (GnRH) Neuronal Cell Migration and Survival

Overview
Date 2013 May 8
PMID 23648337
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

The membrane tyrosine kinase receptors, AXL and MET, are implicated in GnRH neuron migration and/or survival. We hypothesized that the receptors with their ligands, GAS6 and HGF, respectively may cross-talk in GnRH neuronal function. In NLT GnRH neuronal cells, MET co-immunoprecipitated with AXL, although HGF or GAS6 did not transphosphorylate AXL or MET, respectively. Co-expression of a kinase dead AXL blocked HGF activation of MET and indirectly AKT and p38MAPK. Silencing of AXL decreased HGF's ability to phosphorylate MET and activate AXL's downstream effectors, p38MAPK and AKT. HGF/MET signaling modulated neuron migration dependent and independent of AXL co-expression and p38MAPK. Conversely, AXL's control of GnRH neuronal survival was dependent on HGF/MET signaling. Together, these data support that the importance of membrane tyrosine kinase receptor crosstalk to regulate neuronal cell-specific developmental functions.

Citing Articles

PFKP silencing suppresses tumor growth via the AXL-MET axis.

Zhao H, Sun Y, Feng H, Cai J, Liu Y, Li Y Int J Biol Sci. 2024; 20(15):6056-6072.

PMID: 39664584 PMC: 11628322. DOI: 10.7150/ijbs.100525.


AXL as immune regulator and therapeutic target in Acute Myeloid Leukemia: from current progress to novel strategies.

Vandewalle N, De Beule N, De Becker A, de Bruyne E, Menu E, Vanderkerken K Exp Hematol Oncol. 2024; 13(1):99.

PMID: 39367387 PMC: 11453060. DOI: 10.1186/s40164-024-00566-8.


Identifying Qingkailing ingredients-dependent mesenchymal-epithelial transition factor-axiation "π" structuring module with angiogenesis and neurogenesis effects.

Kunming C, Jianan Y, Jun L, Shengpeng Z, Qixiang X, Yong X J Tradit Chin Med. 2024; 44(1):35-43.

PMID: 38213237 PMC: 10774727. DOI: 10.19852/j.cnki.jtcm.2024.01.004.


Preclinical characterization and phase I clinical trial of CT053PTSA targets MET, AXL, and VEGFR2 in patients with advanced solid tumors.

Ma Y, Liu F, Zhang Y, Chen Q, Chen Z, Liu Q Front Immunol. 2022; 13:1024755.

PMID: 36341335 PMC: 9632963. DOI: 10.3389/fimmu.2022.1024755.


Role of p38 MAPK Signalling in Testis Development and Male Fertility.

Luo D, He Z, Yu C, Guan Q Oxid Med Cell Longev. 2022; 2022:6891897.

PMID: 36092154 PMC: 9453003. DOI: 10.1155/2022/6891897.


References
1.
Mars W, Zarnegar R, Michalopoulos G . Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am J Pathol. 1993; 143(3):949-58. PMC: 1887222. View

2.
Tu H, Zhou Z, Liang Q, Li Z, Li D, Qing J . CXCR4 and SDF-1 production are stimulated by hepatocyte growth factor and promote glioma cell invasion. Onkologie. 2009; 32(6):331-6. DOI: 10.1159/000216352. View

3.
Lay J, Hong C, Huang J, Yang Y, Pao C, Liu C . Sulfasalazine suppresses drug resistance and invasiveness of lung adenocarcinoma cells expressing AXL. Cancer Res. 2007; 67(8):3878-87. DOI: 10.1158/0008-5472.CAN-06-3191. View

4.
Wierman M, Pawlowski J, Allen M, Xu M, Linseman D, Nielsen-Preiss S . Molecular mechanisms of gonadotropin-releasing hormone neuronal migration. Trends Endocrinol Metab. 2004; 15(3):96-102. DOI: 10.1016/j.tem.2004.02.003. View

5.
Radovick S, Wray S, Lee E, Nicols D, Nakayama Y, Weintraub B . Migratory arrest of gonadotropin-releasing hormone neurons in transgenic mice. Proc Natl Acad Sci U S A. 1991; 88(8):3402-6. PMC: 51455. DOI: 10.1073/pnas.88.8.3402. View